Upgrade to SI Premium - Free Trial

Viridian Therapeutic (VRDN) PT Lowered to $31 at Goldman Sachs

April 6, 2026 6:01 PM
Goldman Sachs analyst Richard Law ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change